Career Progression - Jessie Hutchens Maxwell

October 29, 2024 11:35 AM

NORTHAMPTON, MA / ACCESSWIRE / October 29, 2024 / Quest Diagnostics From Manual Sample Processor to Bio-Analytical Instrument TechnicianNearly 7 Years with QuestEsoteric Region - Memphis, TennesseeQ: How long have you been at Quest and what was your first role?Jessie: I started at Oxford Immunotec as a temp/contract position on the manual sample processing team before our site was acquired by Quest. I was promoted from the processing line to the...

Read more

Laxxon Medical Names Lauren Chung PhD MBA as Chief Financial Officer

October 29, 2024 11:10 AM

Laxxon Medical Corp., a leading pharma technology platform company focusing on oral drug delivery, today announced the appointment of Lauren Chung PhD MBA, as Chief Financial Officer (CFO). Dr. Chung will be a member of the Executive Leadership Team reporting to Chairman and Chief Executive Officer, Helmut Kerschbaumer. Dr. Chung's appointment is part of Laxxon Medical's broader strategy to transition to a clinical stage company, enhancing their...

Read more

Xponential Fitness Brands Expand to Mexico and Japan

October 29, 2024 10:15 AM

Xponential Fitness partners with experienced master franchisees to drive international growth.SAN DIEGO, CA / ACCESSWIRE / October 29, 2024 / Xponential Fitness, a global franchisor of boutique health and wellness brands, continues expanding internationally. The company recently announced plans to bring three of its popular fitness concepts, Pure Barre, Club Pilates, and Rumble Boxing, to Mexico and Japan, respectively. These moves mark...

Read more

Significant Positive Results with Jaguar Health's Crofelemer for Chronic Refractory Diarrhea in IBS-D, Presented at American College of Gastroenterology Annual Meeting

October 29, 2024 10:00 AM

Jaguar Health, Inc.(NASDAQ:JAGX) ("Jaguar") family company Napo Pharmaceuticals ("Napo") today announced that the abstracts are now available for two independent investigator-initiated studies of crofelemer, Napo's novel, plant-based oral prescription drug, that show a benefit in patients with chronic refractory diarrhea and are the subject of poster presentations taking place today, October 29, 2024, at the American College of Gastroenterology...

Read more

Cellev8 and Zyppah Team Up to Give Snoring a Rest

October 29, 2024 10:00 AM

Cellev8 and Zyppah Announce Collaborative Sales Agreement Targeting 90 Million Snoring Americans.WELLINGTON, FL / ACCESSWIRE / October 29, 2024 / Cellev8 and Zyppah Announce Collaborative Sales Agreement Targeting 90 Million Snoring Americans.Cellev8, a leading provider of Superoxide Dismutase (SOD) gummies, and Zyppah, the innovator of patented anti-snoring devices, have joined forces in a groundbreaking collaborative sales agreement. This...

Read more

Bulletin from the Extraordinary General Meeting in PMD Device Solutions AB (publ)

October 29, 2024 9:30 AM

STOCKHOLM, SWEDEN / ACCESSWIRE / October 29, 2024 / PMD Device Solutions (FRA:8T0)(STO:PMDS) Extraordinary general meeting of PMD Device Solutions AB (publ), reg. no 556639-6809 (the "Company"), was held today, 29 October 2024 at 10.00 CET in Stockholm. The meeting resolved, with required majority, on all proposed matters in accordance with the board's previously announced proposals. The following is a summary of the main decisions...

Read more

Bulletin from the Extraordinary General Meeting in PMD Device Solutions AB (publ)

October 29, 2024 9:30 AM

STOCKHOLM, SWEDEN / ACCESSWIRE / October 29, 2024 / PMD Device Solutions (FRA:8T0)(STO:PMDS) Extraordinary general meeting of PMD Device Solutions AB (publ), reg. no 556639-6809 (the "Company"), was held today, 29 October 2024 at 11.00 CET in Stockholm. The meeting resolved, with required majority, on all proposed matters in accordance with the board's previously announced proposals. The following is a summary of the main decisions...

Read more

Protagenic Therapeutics Announces Pricing of Private Placement for Aggregate Gross Proceeds of $1.275 Million

October 29, 2024 9:27 AM

NEW YORK, NY / ACCESSWIRE / October 29, 2024 / Protagenic Therapeutics, Inc. (Nasdaq:PTIX) ("Protagenic Therapeutics" or the "Company"), a leader in biopharmaceutical innovation, announced today it has entered into a purchase agreement (the "Purchase Agreement") for the purchase and sale of an aggregate of 1,948,295 shares of common stock (or pre-funded warrants in lieu of shares of common stock), series A common stock purchase warrants to...

Read more

Ankle & Foot Centers of America Participates in the Georgia 2-Day Walk for Breast Cancer

October 29, 2024 9:01 AM

Leading podiatrists renew their commitment to public health and community involvement, championing the annual cancer event for the past 22 years.PEACHTREE CITY, GA / ACCESSWIRE / October 29, 2024 / Continuing its two decades-plus of support for the cause, Ankle & Foot Centers of America proudly participated in the Georgia 2-Day Walk for Breast Cancer, offering on-site podiatric support for walkers during the September 28-29 event. Since 2002,...

Read more

Vheda Health Recognized as a Top 100 MBE(R)

October 29, 2024 9:00 AM

Capital Region Minority Supplier Development Council (CRMSDC) honors Vheda Health as one of the best in the region.COLUMBIA, MD / ACCESSWIRE / October 29, 2024 / The Capital Region Minority Supplier Development Council (CRMSDC) is proud to announce that Vheda Health has been named a winner of the 2024 Top 100 MBE® Award. This prestigious accolade recognizes minority business owners in Maryland, Virginia, and the District of Columbia who have...

Read more

KindlyMD(R) Announces New Partnership With Cigna Healthcare to Further Expand Patient Care Accessibility

October 29, 2024 9:00 AM

KindlyMD, Inc. ("KindlyMD" or the "Company") (NASDAQ:KDLY), a patient-first healthcare and healthcare data company uniquely integrating traditional primary care and pain management strategies with integrated behavioral and alternative therapies, today announced it is now contracted with Cigna Healthcare, after receiving additional credentialing.Cigna's innovative approach to behavioral health focuses on integrating mental health services with...

Read more

Luxe Plastic Surgery's Dr. Malik Kutty Warns of the Dangers of Inadequately Trained Plastic Surgeons

October 29, 2024 9:00 AM

SUGAR LAND, TX / ACCESSWIRE / October 29, 2024 / Dr. Malik Kutty of Luxe Plastic Surgery is raising awareness about the growing number of inadequately trained plastic surgeons, a trend he says is putting patients at serious risk for adverse health issues.As demand for cosmetic procedures continues to rise, more and more patients are seeking aesthetic treatments. Unfortunately, and perhaps predictably, this surge has coincided with an increase in...

Read more

UTMD Reports Financial Performance for Third Calendar Quarter and Nine Months 2024

October 29, 2024 9:00 AM

Utah Medical Products, Inc. (NASDAQ:UTMD) reports third quarter (3Q) and first nine months (9M) of calendar year 2024 financial results that were weaker on the top line, but better on the bottom line, compared to its beginning of year projections.Currencies in this release are denoted as $ or USD = U.S. Dollars; AUD = Australia Dollars; £ or GBP = UK Pound Sterling; C$ or CAD = Canadian Dollars; and € or EUR = Euros. Currency amounts throughout...

Read more

Aptevo Therapeutics and Alligator Bioscience to Present Additional Positive Interim Phase 1 Data Evaluating ALG.APV-527 Monotherapy in Multiple Solid Tumor Types, at SITC 2024

October 29, 2024 8:05 AM

Aptevo Therapeutics ("Aptevo") (NASDAQ:APVO) and Alligator Bioscience AB ("Alligator") (ATORX) today announced that new, positive interim data from the dose escalation phase of their Phase 1 trial evaluating ALG.APV-527 will be presented in a poster session on Friday, November 8, 2024, at the Society for Immunotherapy of Cancer 2024 (SITC), taking place November 6th - 10th, 2024 in Houston, Texas.Presentation DetailsPoster number: #673Title:...

Read more

CBD Life Sciences Inc. (CBDL) Announces Grand View Research Report Findings on High-Growth CBD Equine Market, Aiming to Drive Unprecedented Shareholder Value

October 29, 2024 8:00 AM

The global CBD pet care market, which includes products for animals like dogs, cats, and horses, was valued at approximately $125 million in 2020 and is expected to grow at a compound annual growth rate (CAGR) of 40.3% from 2021 to 2028.SCOTTSDALE, AZ / ACCESSWIRE / October 29, 2024 / CBD Life Sciences Inc. (CBDL), an innovative leader in the CBD industry, is positioning itself to capitalize on the rapidly expanding CBD pet care market with a...

Read more

Dr. Falk Pharma Acquires Kynos Therapeutics, Adding Acute Pancreatitis as a Therapeutic Focus and Further Strengthening Its Development Portfolio

October 29, 2024 8:00 AM

FREIBURG, GERMANY / ACCESSWIRE / October 29, 2024 / Today, Dr. Falk Pharma GmbH announces the successful acquisition of Kynos Therapeutics Ltd., a clinical stage biopharmaceutical company focusing on the development of novel treatments for patients suffering from acute and chronic inflammatory diseases. The company was founded as a spin-out of the University of Edinburgh, Scotland, together with lead investor Epidarex Capital, a leading...

Read more

180 Life Sciences Corp. Appoints Mr. Jay Goodman to Board of Directors

October 29, 2024 8:00 AM

PALO ALTO, CA / ACCESSWIRE / October 29, 2024 / 180 Life Sciences Corp. ("180" or the "Company") (NASDAQ:ATNF) today announced the appointment of Mr. Jay Goodman to its Board of Directors, effective immediately. Mr. Goodman brings over a decade of expertise in the software-as-a-service (SaaS) and iGaming industries, along with more than seven years of experience in executive leadership roles. Mr. Goodman's distinguished career includes...

Read more

Sensio Air Wins Prestigious Red Dot Award for Design Excellence

October 29, 2024 8:00 AM

Innovative Airborne Pathogen Monitoring Device Recognized for Outstanding Design and FunctionalitySUNNYVALE, CA / ACCESSWIRE / October 29, 2024 / Sensio Air, a leading innovator in artificial intelligence pathogen monitoring solutions, has been awarded the prestigious Red Dot Design Award. This accolade is a testament to Sensio Air's commitment to creating high-quality, user-centric products that enhance people's lives and improve health and...

Read more

Avinger to Announce Third Quarter 2024 Results on November 7, 2024

October 29, 2024 8:00 AM

Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for diagnosis and treatment of vascular disease, today announced that it will release its financial results for the third quarter 2024 after the close of trading on Thursday, November 7, 2024. The Company will host a conference call beginning at 1:30pm PT/4:30pm ET.To join the call by telephone,...

Read more

Quantum Biopharma Announces that Sentinel Dosing has Started for the Phase-1 Multiple Ascending Dose Clinical Trial for Lucid-21-302 (Lucid-Ms) in Australia

October 29, 2024 7:30 AM

Quantum BioPharma Ltd. (NASDAQ:QNTM)(CSE:QNTM)(FRA:0K91) ("Quantum BioPharma" or the "Company"), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions, today announces through its subsidiary, HUGE Biopharma Australia Pty Ltd., that sentinel dosing has started its trial entitled "A Phase 1, Randomised, Double-Blind, Placebo-Controlled, Multiple Ascending Dose Study to Evaluate the Safety and...

Read more